Multivariate analysis in terms of OS and PFS of patients with DLBCL treated with R-CHOP
| . | HR . | 95% CI . | P . |
|---|---|---|---|
| OS | |||
| IPI > 2 | 2.63 | 1.87-3.69 | < .0001 |
| TP53 mutation | 1.95 | 1.34-2.83 | .0004 |
| ABC subtype | 1.62 | 1.15-2.28 | .0062 |
| B symptoms | 1.43 | 1.02-2.01 | .0374 |
| PFS | |||
| IPI > 2 | 2.45 | 1.77-3.39 | < .0001 |
| TP53 mutation | 1.84 | 1.28-2.65 | .0010 |
| ABC subtype | 1.60 | 1.15-2.24 | .0052 |
| B symptoms | 1.43 | 1.03-1.99 | .0323 |
| . | HR . | 95% CI . | P . |
|---|---|---|---|
| OS | |||
| IPI > 2 | 2.63 | 1.87-3.69 | < .0001 |
| TP53 mutation | 1.95 | 1.34-2.83 | .0004 |
| ABC subtype | 1.62 | 1.15-2.28 | .0062 |
| B symptoms | 1.43 | 1.02-2.01 | .0374 |
| PFS | |||
| IPI > 2 | 2.45 | 1.77-3.39 | < .0001 |
| TP53 mutation | 1.84 | 1.28-2.65 | .0010 |
| ABC subtype | 1.60 | 1.15-2.24 | .0052 |
| B symptoms | 1.43 | 1.03-1.99 | .0323 |